会议报告:第34届抗病毒研究国际会议。

Q2 Pharmacology, Toxicology and Pharmaceutics Antiviral Chemistry and Chemotherapy Pub Date : 2022-01-01 DOI:10.1177/20402066221130853
Andrea Brancale, Kara Carter, Leen Delang, Jerome Deval, David Durantel, Brian G Gentry, Robert Jordan, Justin G Julander, Michael K Lo, Maria-Jesús Pérez-Pérez, Luis M Schang, Katherine L Seley-Radtke, Pei-Yong Shi, Subhash G Vasudevan, Richard J Whitley, Jessica R Spengler
{"title":"会议报告:第34届抗病毒研究国际会议。","authors":"Andrea Brancale,&nbsp;Kara Carter,&nbsp;Leen Delang,&nbsp;Jerome Deval,&nbsp;David Durantel,&nbsp;Brian G Gentry,&nbsp;Robert Jordan,&nbsp;Justin G Julander,&nbsp;Michael K Lo,&nbsp;Maria-Jesús Pérez-Pérez,&nbsp;Luis M Schang,&nbsp;Katherine L Seley-Radtke,&nbsp;Pei-Yong Shi,&nbsp;Subhash G Vasudevan,&nbsp;Richard J Whitley,&nbsp;Jessica R Spengler","doi":"10.1177/20402066221130853","DOIUrl":null,"url":null,"abstract":"<p><p>As a result of the multiple gathering and travels restrictions during the SARS-CoV-2 pandemic, the annual meeting of the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR), could not be held in person in 2021. Nonetheless, ISAR successfully organized a remote conference, retaining the most critical aspects of all ICARs, a collegiate gathering of researchers in academia, industry, government and non-governmental institutions working to develop, identify, and evaluate effective antiviral therapy for the benefit of all human beings. This article highlights the 2021 remote meeting, which presented the advances and objectives of antiviral and vaccine discovery, research, and development. The meeting resulted in a dynamic and effective exchange of ideas and information, positively impacting the prompt progress towards new and effective prophylaxis and therapeutics.</p>","PeriodicalId":7960,"journal":{"name":"Antiviral Chemistry and Chemotherapy","volume":" ","pages":"20402066221130853"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/43/3a/10.1177_20402066221130853.PMC9623364.pdf","citationCount":"3","resultStr":"{\"title\":\"Meeting report: 34th international conference on antiviral research.\",\"authors\":\"Andrea Brancale,&nbsp;Kara Carter,&nbsp;Leen Delang,&nbsp;Jerome Deval,&nbsp;David Durantel,&nbsp;Brian G Gentry,&nbsp;Robert Jordan,&nbsp;Justin G Julander,&nbsp;Michael K Lo,&nbsp;Maria-Jesús Pérez-Pérez,&nbsp;Luis M Schang,&nbsp;Katherine L Seley-Radtke,&nbsp;Pei-Yong Shi,&nbsp;Subhash G Vasudevan,&nbsp;Richard J Whitley,&nbsp;Jessica R Spengler\",\"doi\":\"10.1177/20402066221130853\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>As a result of the multiple gathering and travels restrictions during the SARS-CoV-2 pandemic, the annual meeting of the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR), could not be held in person in 2021. Nonetheless, ISAR successfully organized a remote conference, retaining the most critical aspects of all ICARs, a collegiate gathering of researchers in academia, industry, government and non-governmental institutions working to develop, identify, and evaluate effective antiviral therapy for the benefit of all human beings. This article highlights the 2021 remote meeting, which presented the advances and objectives of antiviral and vaccine discovery, research, and development. The meeting resulted in a dynamic and effective exchange of ideas and information, positively impacting the prompt progress towards new and effective prophylaxis and therapeutics.</p>\",\"PeriodicalId\":7960,\"journal\":{\"name\":\"Antiviral Chemistry and Chemotherapy\",\"volume\":\" \",\"pages\":\"20402066221130853\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/43/3a/10.1177_20402066221130853.PMC9623364.pdf\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antiviral Chemistry and Chemotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/20402066221130853\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antiviral Chemistry and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20402066221130853","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 3

摘要

由于SARS-CoV-2大流行期间的多次聚集和旅行限制,国际抗病毒研究学会(ISAR)年会——国际抗病毒研究会议(ICAR)无法在2021年亲自举行。尽管如此,ISAR成功地组织了一次远程会议,保留了所有ICARs的最关键方面,这是学术界、工业界、政府和非政府机构的研究人员的一次合议聚会,致力于开发、确定和评估有效的抗病毒治疗,以造福全人类。本文重点介绍了2021年远程会议,该会议介绍了抗病毒药物和疫苗发现、研究和开发的进展和目标。会议进行了积极和有效的思想和信息交流,积极影响了在新的和有效的预防和治疗方法方面的迅速进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Meeting report: 34th international conference on antiviral research.

As a result of the multiple gathering and travels restrictions during the SARS-CoV-2 pandemic, the annual meeting of the International Society for Antiviral Research (ISAR), the International Conference on Antiviral Research (ICAR), could not be held in person in 2021. Nonetheless, ISAR successfully organized a remote conference, retaining the most critical aspects of all ICARs, a collegiate gathering of researchers in academia, industry, government and non-governmental institutions working to develop, identify, and evaluate effective antiviral therapy for the benefit of all human beings. This article highlights the 2021 remote meeting, which presented the advances and objectives of antiviral and vaccine discovery, research, and development. The meeting resulted in a dynamic and effective exchange of ideas and information, positively impacting the prompt progress towards new and effective prophylaxis and therapeutics.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Antiviral Chemistry and Chemotherapy
Antiviral Chemistry and Chemotherapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.20
自引率
0.00%
发文量
5
审稿时长
15 weeks
期刊介绍: Antiviral Chemistry & Chemotherapy publishes the results of original research concerned with the biochemistry, mode of action, chemistry, pharmacology and virology of antiviral compounds. Manuscripts dealing with molecular biology, animal models and vaccines are welcome. The journal also publishes reviews, pointers, short communications and correspondence.
期刊最新文献
The continuing need for therapeutic agents for respiratory syncytial virus infection. The development of BVDU: An odyssey. Meeting report: 34th international conference on antiviral research. Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens. Reflections on the Rega Institute for Medical Research, at the fiftieth anniversary of the Rega Stichting vzw (Rega Instituut vzw, Rega Foundation).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1